Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FP55R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,167
Award facts
- Contract value 100% obligated
- $16,167.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On August 11, 2025, the Defense Logistics Agency awarded a delivery order valued at $16,167.17 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens. This competitive, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. Dupixent (dupilumab) is a biologic immunosuppressant used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and other inflammatory conditions, and this procurement supports the Defense Health Agency's pharmaceutical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply military healthcare programs and other federal healthcare systems, positioning AmerisourceBergen Drug Corp as a key provider within the Defense Logistics Agency's Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FP55R?
SPE2DB25FP55R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FP55R worth?
The government has obligated $16,167 on SPE2DB25FP55R.
Is contract SPE2DB25FP55R an order under another contract?
Yes. SPE2DB25FP55R is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP55R competed?
The extent of competition for SPE2DB25FP55R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award